Li X, Gonzalez-Maroto C, Tavassoli M
Cell Death Discov. 2024; 10(1):303.
PMID: 38926351
PMC: 11208506.
DOI: 10.1038/s41420-024-02053-9.
Mirzaie M, Gholizadeh E, Miettinen J, Ianevski F, Ruokoranta T, Saarela J
Oncogenesis. 2024; 13(1):11.
PMID: 38429288
PMC: 10907624.
DOI: 10.1038/s41389-024-00510-9.
Carter-Su C, Argetsinger L, Svezhova N
Am J Physiol Endocrinol Metab. 2023; 325(5):E425-E437.
PMID: 37672248
PMC: 10874654.
DOI: 10.1152/ajpendo.00265.2023.
Tian Y, Qin S, Zhang F, Luo J, He X, Sun Y
ACS Med Chem Lett. 2023; 14(8):1113-1121.
PMID: 37583815
PMC: 10424325.
DOI: 10.1021/acsmedchemlett.3c00251.
Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q
Signal Transduct Target Ther. 2023; 8(1):204.
PMID: 37208335
PMC: 10196327.
DOI: 10.1038/s41392-023-01468-7.
Low-Dose IL-2 Attenuated Depression-like Behaviors and Pathological Changes through Restoring the Balances between IL-6 and TGF-β and between Th17 and Treg in a Chronic Stress-Induced Mouse Model of Depression.
Huang C, Zhang F, Li P, Song C
Int J Mol Sci. 2022; 23(22).
PMID: 36430328
PMC: 9699071.
DOI: 10.3390/ijms232213856.
Leptin in Human Milk-One of the Key Regulators of Nutritional Programming.
Sinkiewicz-Darol E, Adamczyk I, Lubiech K, Pilarska G, Twaruzek M
Molecules. 2022; 27(11).
PMID: 35684517
PMC: 9182392.
DOI: 10.3390/molecules27113581.
Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism.
Xie L, Xiao Y, Tai S, Yang H, Zhou S, Zhou Z
Front Pharmacol. 2022; 13:836849.
PMID: 35295328
PMC: 8920092.
DOI: 10.3389/fphar.2022.836849.
Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death.
Hu Z, Ju F, Du L, Abbott G
Cardiovasc Diabetol. 2021; 20(1):199.
PMID: 34607570
PMC: 8491391.
DOI: 10.1186/s12933-021-01392-6.
HuR Plays a Positive Role to Strengthen the Signaling Pathways of CD4 T Cell Activation and Th17 Cell Differentiation.
Yu S, Tripod M, Atasoy U, Chen J
J Immunol Res. 2021; 2021:9937243.
PMID: 34395636
PMC: 8357502.
DOI: 10.1155/2021/9937243.
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q
Signal Transduct Target Ther. 2021; 6(1):218.
PMID: 34108441
PMC: 8190181.
DOI: 10.1038/s41392-021-00641-0.
Leptin and Obesity: Role and Clinical Implication.
Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart A
Front Endocrinol (Lausanne). 2021; 12:585887.
PMID: 34084149
PMC: 8167040.
DOI: 10.3389/fendo.2021.585887.
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease.
Veiga C, Lawrence E, Murphy A, Herold M, Dragoljevic D
Cancers (Basel). 2021; 13(8).
PMID: 33921778
PMC: 8073047.
DOI: 10.3390/cancers13081968.
The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials.
Li X, Wang F, Xu X, Zhang J, Xu G
Front Cell Dev Biol. 2021; 9:636595.
PMID: 33834023
PMC: 8021797.
DOI: 10.3389/fcell.2021.636595.
Regulation of Metabolic Health by an "Olfactory-Hypothalamic Axis" and Its Possible Implications for the Development of Therapeutic Approaches for Obesity and T2D.
Guzman-Ruiz M, Jimenez A, Cardenas-Rivera A, Guerrero-Vargas N, Organista-Juarez D, Guevara-Guzman R
Cell Mol Neurobiol. 2021; 42(6):1727-1743.
PMID: 33813677
PMC: 11421737.
DOI: 10.1007/s10571-021-01080-9.
Agonistic CD40 Antibodies in Cancer Treatment.
Djureinovic D, Wang M, Kluger H
Cancers (Basel). 2021; 13(6).
PMID: 33804039
PMC: 8000216.
DOI: 10.3390/cancers13061302.
Microtubule-dependent mechanism of anti-inflammatory effect of SOCS1 in endothelial dysfunction and lung injury.
Karki P, Cha B, Zhang C, Li Y, Ke Y, Promnares K
FASEB J. 2021; 35(4):e21388.
PMID: 33724556
PMC: 10069762.
DOI: 10.1096/fj.202001477RR.
Supraphysiological Levels of IL-2 in Jak3-Deficient Mice Promote Strong Proliferative Responses of Adoptively Transferred Naive CD8 T Cells.
Lee G, Lee S, Kim J, Ju Y, Kim H, Yun C
Front Immunol. 2021; 11:616898.
PMID: 33584707
PMC: 7876067.
DOI: 10.3389/fimmu.2020.616898.
Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance.
Wu H, You L, Li Y, Zhao Z, Shi G, Chen Z
Cancer Res. 2020; 80(13):2927-2939.
PMID: 32341037
PMC: 9601976.
DOI: 10.1158/0008-5472.CAN-19-2549.
Targeting cancer stem cell pathways for cancer therapy.
Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J
Signal Transduct Target Ther. 2020; 5(1):8.
PMID: 32296030
PMC: 7005297.
DOI: 10.1038/s41392-020-0110-5.